Pitch prize in Bordeaux

by admin
maj 12, 2022

The MTHFD2 program is pitched by CEO Dr Ana Slipicevic at the Meet2Win conference in Bordeaux and wins a pitch price!

Rekommenderade artiklar

Detailed mode of action of the MTHFD1/2 inhibitor TH9619 now published in Nature Metabolism

The One-carbon Therapeutics team is proud and excited to share

We are presenting our novel MTHFD1/2 inhibitor at the DDR inhibitor summit

We are presenting our data at the DDR inhibitor summit,

One-carbon Therapeutics receives US patent

We are happy to announce that on the 22nd of

Menu bar